Passende vaccination (hepatitis A og B) bør overvejes for patienter i regelmæssig / gentagen behandling med humane plasmaudvundne Protein C produkter.
Appropriate vaccination (hepatitis A and B) should be considered for patients in regular / repeated receipt of human plasma-derived Protein C products.